Physician

John Edward Weisenberger, M.D.

According to 2025 Medicare claims, John Weisenberger, M.D. (NPI: 1184736548) practices family practice in the Hanford-Corcoran, CA market, with the plurality of this provider's patient population coming from Kings, CA. Weisenberger uses personal NPI as billing NPI and primary practice location at 93230-9998.

Weisenberger's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 177 traditional Medicare patients, billed 1,326 HCPCS/CPT codes, and received $59,482 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,207 prescription claims across 256 beneficiaries totaling $600,772 in drug costs, led by Ozempic (Semaglutide). DME data shows 76 claims. Open Payments data shows 28 records totaling $1,172. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $383,144 to $600,772. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $28,943 to $4,930.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	251	8,804	$71,064
2016	228	8,765	$71,605
2017	229	4,938	$65,257
2018	213	5,311	$58,969
2019	226	6,420	$64,388
2020	217	5,093	$52,063
2021	207	4,635	$58,042
2022	203	3,957	$56,793
2023	189	2,967	$54,197
2024	177	1,326	$59,482

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	244	7,370	$383,144
2016	248	6,652	$382,809
2017	239	5,781	$379,412
2018	235	5,350	$389,412
2019	245	5,526	$447,723
2020	246	5,633	$497,430
2021	255	5,633	$507,503
2022	258	5,878	$516,819
2023	243	5,634	$538,545
2024	256	6,207	$600,772

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	100	338	$13,991
2016	80	297	$8,133
2017	44	243	$10,754
2018	45	253	$8,670
2019	39	151	$2,498
2020	44	221	$4,566
2021	22	173	$4,208
2022	22	191	$4,834
2023	29	208	$8,649
2024	11	76	$1,551

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	151	364	$86
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	152	492	$52

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	66	2,128	$66,574
Jardiance	Empagliflozin	51	3,420	$62,445
Mounjaro	Tirzepatide	56	1,626	$58,999
Farxiga	Dapagliflozin Propanediol	33	2,670	$47,796
Januvia	Sitagliptin Phosphate	34	2,250	$38,922

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	15	$841
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	11	34	$540
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	12	$147
A4259	Lancets, per box of 100	N	N/R	15	$23

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	28	$1,172	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John Edward Weisenberger, M.D.?

Tedicare shows public-source Medicare data for John Edward Weisenberger, M.D. (NPI 1184736548), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Edward Weisenberger, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John Edward Weisenberger, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does John Edward Weisenberger, M.D. have Open Payments data?

John Edward Weisenberger, M.D. has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.